Home / Companies / ORIC Pharmaceuticals, Inc. / 12 Jun 2024
ORIC Pharmaceuticals, Inc.: meeting of 12 Jun 2024
Votes reported on Form N-PX, item by item
79 Form N-PX filers reported votes at the ORIC Pharmaceuticals, Inc. meeting of 12 Jun 2024. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 71.3% of reported votes for; 39 filers withheld from or voted against at least one nominee.
292 vote records from 79 filers. 3 of the 79 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
146 vote records from 79 filers. 0 of the 79 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | For | For |
| American Century | Split or no vote | For |
| Franklin Templeton | For | For |
| Invesco | Split or no vote | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | Split or no vote | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Goldman Sachs | Split or no vote | For |
| Jackson National funds | Abstain or withhold * | For |
| SEI | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | For |
| Voya | Split or no vote | For |
| Nationwide | For | For |
| Victory Capital | Split or no vote | For |
| Brighthouse Funds | Split or no vote | For |
| Guggenheim and Rydex | Split or no vote | For |
| BNY Mellon | Split or no vote | For |
| Principal | Split or no vote | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| DWS | Split or no vote | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the ORIC Pharmaceuticals, Inc. meeting?
79 Form N-PX filers reported votes at the meeting of 12 Jun 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by ORIC Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for ORIC Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing ORIC Pharmaceuticals, Inc. with a meeting date within three days of 12 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.